SCHEMBL12825547

SCHEMBL12825547

Cc1cc(N)ccc1-c1ccc2[nH]c(-c3c(F)cc(OCCO)cc3F)cc2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 2/20 0.38
PRKAB2 O43741 3/20 0.36
PRKAG1 P54619 3/20 0.36
PRKAA2 P54646 3/20 0.36
PRKAA1 Q13131 3/20 0.36
PRKAG3 Q9UGI9 3/20 0.36
PRKAG2 Q9UGJ0 3/20 0.36
PRKAB1 Q9Y478 3/20 0.36
FFAR1 O14842 6/20 0.35
PPARG P37231 2/20 0.35
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
NPC1 O15118 1/20 0.34
ALDH1A1 P00352 1/20 0.34
MAPT P10636 1/20 0.34
HPGD P15428 1/20 0.34
RAB9A P51151 1/20 0.34
GFER P55789 1/20 0.34
KMT2A Q03164 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12826823 0.96 AURKA (0.38) CYP1A1PRKAB2PRKAG1PRKAA2PRKAA1
SCHEMBL12826907 0.92 CYP1A1 (0.38) CYP1A1FFAR1PPARGKDM4EMEN1
SCHEMBL12826908 0.91 CYP1A1 (0.37) CYP1A1FFAR1PPARGKDM4EMEN1
SCHEMBL12825989 0.86 CYP1A1 (0.41) CYP1A1PRKAB2PRKAG1PRKAA2PRKAA1
SCHEMBL1459945 0.85 HRH2 (0.41) PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3
SCHEMBL1460274 0.82 HRH2 (0.41) PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3
SCHEMBL12825966 0.80 ORAI1 (0.39) CYP1A1KDM4EMEN1NPC1ALDH1A1
SCHEMBL1458899 0.77 CYP19A1 (0.38)
SCHEMBL12826229 0.76 HRH2 (0.38) CYP1A1
SCHEMBL1459793 0.76 HRH2 (0.38) PRKAG1PRKAA2PRKAB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011036130-A1 INDOLE DERIVATIVES AS CRAC MODULATORS F. HOFFMANN-LA ROCHE AG (CH) 2011-03-31 WO disclosed